Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -9.01% is 45% above its 5-year average of -16.25%, near the high end of its 5-year range (-27.27%–-5.77%).
16.79% above its 12-month average of -10.83%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -5.77%.
OPERATING MARGIN
-9.01%
OPERATING MARGIN AVG TTM
-10.83%
OPERATING MARGIN AVG 3Y
-14.72%
OPERATING MARGIN AVG 5Y
-16.25%
OPERATING MARGIN AVG 10Y
-17.17%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+16.79%
CURRENT VS 3Y AVG
+38.77%
CURRENT VS 5Y AVG
+44.54%
CURRENT VS 10Y AVG
+47.52%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 643 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
OrthoPediatrics Corp.
Market Cap
$585.62M
Operating Margin
-9.01%
TTM Avg
-10.83%
3Y Avg
-14.72%
5Y Avg
-16.25%
Market Cap
$600.01M
Operating Margin
40.10%
TTM Avg
33.30%
3Y Avg
-21.49%
5Y Avg
1.14%
Market Cap
$600.51M
Operating Margin
-28.23%
TTM Avg
-27.16%
3Y Avg
-23.27%
5Y Avg
7.30%
Market Cap
$568.99M
Operating Margin
-156.36%
TTM Avg
-104.91%
3Y Avg
-81.98%
5Y Avg
-81.61%
Market Cap
$567.12M
Operating Margin
-29.35%
TTM Avg
-5.63%
3Y Avg
-52.07%
5Y Avg
-106.16%
Market Cap
$563.68M
Operating Margin
46.95%
TTM Avg
-1.63%
3Y Avg
-11705.79%
5Y Avg
-12269.85%
Market Cap
$609.24M
Operating Margin
-12.47%
TTM Avg
-13.07%
3Y Avg
-26.14%
5Y Avg
-20.95%
Market Cap
$561.45M
Operating Margin
-975.91%
TTM Avg
-867.04%
3Y Avg
-586.91%
5Y Avg
-743.36%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OrthoPediatrics Corp. (KIDS) | $585.62M | -9.01% | -10.83% | -14.72% | -16.25% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $600.01M | 40.10% | 33.30% | -21.49% | 1.14% |
| Fulgent Genetics, Inc. (FLGT)vs › | $600.51M | -28.23% | -27.16% | -23.27% | 7.30% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $568.99M | -156.36% | -104.91% | -81.98% | -81.61% |
| CytomX Therapeutics, Inc. (CTMX)vs › | $567.12M | -29.35% | -5.63% | -52.07% | -106.16% |
| CorMedix Inc. (CRMD)vs › | $563.68M | 46.95% | -1.63% | -11705.79% | -12269.85% |
| AngioDynamics, Inc. (ANGO)vs › | $609.24M | -12.47% | -13.07% | -26.14% | -20.95% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $561.45M | -975.91% | -867.04% | -586.91% | -743.36% |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $552.54M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
73.7%
Operating Margin
-9.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -5.77% |
| 2026-03-31 | -14.04% |
| 2025-12-31 | -8.94% |
| 2025-09-30 | -7.94% |
| 2025-06-30 | -17.45% |
| 2025-03-31 | -20.95% |
| 2024-12-31 | -26.69% |
| 2024-09-30 | -10.20% |
| 2024-06-30 | -10.73% |
| 2024-03-31 | -21.76% |
| 2023-12-31 | -21.44% |
| 2023-09-30 | -11.28% |
| 2023-06-30 | -14.12% |
| 2023-03-31 | -27.20% |
| 2022-12-31 | -26.81% |
| 2022-09-30 | -9.59% |
| 2022-06-30 | -11.37% |
| 2022-03-31 | -27.27% |
| 2021-12-31 | -22.41% |
| 2021-09-30 | -14.53% |
| 2021-06-30 | -10.66% |
| 2021-03-31 | -27.83% |
| 2020-12-31 | -67.34% |
| 2020-09-30 | -11.25% |
| 2020-06-30 | -51.62% |
| 2020-03-31 | -27.49% |
| 2019-12-31 | -15.99% |
| 2019-09-30 | -7.42% |
| 2019-06-30 | -9.84% |
| 2019-03-31 | -18.54% |
| 2018-12-31 | -12.81% |
| 2018-09-30 | -7.41% |
| 2018-06-30 | -14.06% |
| 2018-03-31 | -36.34% |
| 2017-12-31 | -35.99% |
| 2017-09-30 | -6.11% |
| 2017-06-30 | -5.74% |
| 2017-03-31 | -8.57% |
| 2016-12-31 | -34.53% |
| 2016-09-30 | -5.16% |
| 2016-06-30 | -8.94% |
| 2016-03-31 | -18.41% |
| 2015-03-31 | -29.84% |
